• Evexia Lifecare reported audited standalone net profit of Rs 152.10 lakhs for FY2026, with revenue of Rs 10,635.03 lakhs.
• Auditors issued a qualified opinion citing lack of expected credit loss provisions on Rs 735.13 lakhs loans and Rs 2,943.89 lakhs trade receivables.
• The company extended FCCB conversion/redemption period from March 2026 to February 2028, deferring conversion obligations.
• Subsidiary Kavit Edible Oil Limited suspended operations since 2019 with negative net worth, raising going concern doubts.